Literature DB >> 1692843

Normative data on the Boston Diagnostic Aphasia Examination in a Spanish-speaking population.

M Rosselli1, A Ardila, A Florez, C Castro.   

Abstract

Normative data of the Boston Diagnostic Aphasia Examination (Goodglass & Kaplan, 1972) in a Spanish-speaking population is presented. This test was given to 180 neurologically normal adults grouped according to three variables: sex, age, and educational level. The statistically significant differences found are presented. Few differences appeared between sexes, but there were marked differences among the different age groups and in particular among educational levels. A correction to the scoring is proposed for each of the subtests according the patient's educational level.

Entities:  

Mesh:

Year:  1990        PMID: 1692843     DOI: 10.1080/01688639008400977

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  4 in total

1.  Averbia as a selective naming disorder: a single case report.

Authors:  A Ardila; M Rosselli
Journal:  J Psycholinguist Res       Date:  1994-03

2.  A tutorial on aphasia test development in any language: Key substantive and psychometric considerations.

Authors:  Maria V Ivanova; Brooke Hallowell
Journal:  Aphasiology       Date:  2013-01-01       Impact factor: 2.773

Review 3.  Multidimensional Clinical Assessment in Frontotemporal Dementia and Its Spectrum in Latin America and the Caribbean: A Narrative Review and a Glance at Future Challenges.

Authors:  Fernando Henríquez; Victoria Cabello; Sandra Baez; Leonardo Cruz de Souza; Patricia Lillo; David Martínez-Pernía; Loreto Olavarría; Teresa Torralva; Andrea Slachevsky
Journal:  Front Neurol       Date:  2022-02-16       Impact factor: 4.003

4.  The state of neuropsychological test norms for Spanish-speaking adults in the United States.

Authors:  Alejandra Morlett Paredes; Amanda Gooding; Lidia Artiola I Fortuny; Monica Rivera Mindt; Paola Suárez; Travis M Scott; Anne Heaton; Robert K Heaton; Mariana Cherner; María J Marquine
Journal:  Clin Neuropsychol       Date:  2020-03-06       Impact factor: 3.535

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.